Ramy Mahmoud Net Worth

The estimated Net Worth of Ramy A Mahmoud is at least 3.08 百万$ dollars as of 17 July 2024. Ramy Mahmoud owns over 111,426 units of OptiNose Inc stock worth over 1,110,420$ and over the last 7 years he sold OPTN stock worth over 535,704$. In addition, he makes 1,437,940$ as President、 Chief Operating Officer at OptiNose Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Ramy Mahmoud OPTN stock SEC Form 4 insiders trading

Ramy has made over 21 trades of the OptiNose Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently he sold 111,426 units of OPTN stock worth 127,026$ on 17 July 2024.

The largest trade he's ever made was exercising 255,427 units of OptiNose Inc stock on 23 November 2020 worth over 416,346$. On average, Ramy trades about 25,903 units every 48 days since 2017. As of 17 July 2024 he still owns at least 1,206,978 units of OptiNose Inc stock.

You can see the complete history of Ramy Mahmoud stock trades at the bottom of the page.

Ramy Mahmoud biography

DR. Ramy A. Mahmoud M.D. serves as President, Chief Operating Officer of the Company. Dr. Mahmoud has served as our President and Chief Operating Officer since 2010. Prior to joining us, Dr. Mahmoud spent 14 years at Johnson & Johnson, where he served as Chief Medical Officer and a member of the Global Management Board of the Ethicon group of companies. During his tenure at Johnson & Johnson, he also held senior roles in the pharmaceutical sector. Dr. Mahmoud served for 10 years on active duty in the U.S. Army and an additional 10 years in the Army Reserves, achieving the rank of Lieutenant Colonel. During his military service, Dr. Mahmoud held various patient care, research, and academic positions, culminating in his position as the head of the Department of Epidemiology at the Walter Reed Army Institute of Research. He has published more than 50 peer-reviewed papers and textbook chapters, and has served as a scientific reviewer for a number of journals and textbooks. Dr. Mahmoud earned a Master of Healthcare Management and Policy degree from the Harvard School of Public Health and an M.D. from the University of Miami. He has earned board certification in both Public Health/Preventive Medicine and in Internal Medicine.

What is the salary of Ramy Mahmoud?

As the President、 Chief Operating Officer of OptiNose Inc, the total compensation of Ramy Mahmoud at OptiNose Inc is 1,437,940$. There are 1 executives at OptiNose Inc getting paid more, with Peter Miller having the highest compensation of 2,033,500$.

How old is Ramy Mahmoud?

Ramy Mahmoud is 55, he's been the President、 Chief Operating Officer of OptiNose Inc since 2010. There are 9 older and 7 younger executives at OptiNose Inc. The oldest executive at OptiNose Inc is Sandra Helton, 70, who is the Independent Director.

What's Ramy Mahmoud's mailing address?

Ramy's mailing address filed with the SEC is C/O OPTINOSE, INC., 777 TOWNSHIP LINE ROAD, SUITE 300, YARDLEY, PA, 19067.

Insiders trading at OptiNose Inc

Over the last 19 years, insiders at OptiNose Inc have traded over 144,654,703$ worth of OptiNose Inc stock and bought 116,688 units worth 814,936$ . The most active insiders traders include Sriram Venkataraman、Capital Partners Ii Gp, Llc...、Rajat Rai. On average, OptiNose Inc executives and independent directors trade stock every 26 days with the average trade being worth of 106,645$. The most recent stock trade was executed by Anthony J Krick on 17 July 2024, trading 6,845 units of OPTN stock currently worth 7,803$.

What does OptiNose Inc do?

optinose, inc., established in 2010 and headquartered in yardley, pennsylvania, is a publicly traded, global specialty pharmaceutical company focused on serving the needs of patients cared for by ent and allergy specialists. our team of kind, passionate, innovative people is building a new kind of organization without the encumbrances of a company with legacy systems and beliefs. we are unified by a shared mission: to improve lives. we do this while also creating great value for the healthcare system and great outcomes for our stakeholders. as innovators in every aspect of our work, we pursue faster and less costly product development, explore evolving commercial business models, and actively seek innovative ways to be more effective and efficient in all areas of the business. we operate with an overarching commitment to doing what is right. we are committed to working together as a team that chooses to live every day by core company values that guide our daily behaviors, creating a fo

Complete history of Ramy Mahmoud stock trades at OptiNose Inc

OptiNose Inc executives and stock owners

OptiNose Inc executives and other stock owners filed with the SEC include:

• Peter Miller,
  Chief Executive Officer, Director
• Ramy Mahmoud,
  President, Chief Operating Officer
• Michael Marino,
  Chief Legal Officer and Corporate Secretary
• Peter K. Miller,
  CEO & Director
• Keith Goldan,
  Chief Financial Officer
• Dr. Ramy A. Mahmoud M.D., M.P.H.,
  Pres & COO
• Michael F. Marino,
  Chief Legal Officer & Corp. Sec.
• Keith Alan Goldan,
  Chief Financial Officer
• Victor M. Clavelli,
  Chief Commercial Officer
• Michael F. Marino Esq.,
  Chief Legal Officer & Corp. Sec.
• Joseph Scodari,
  Independent Chairman of the Board
• Sandra Helton,
  Independent Director
• Wilhelmus Groenhuysen,
  Independent Director
• William Doyle,
  Independent Director
• Jonathan Neely,
  VP Investor Relations and Business Operations
• Catherine Owen,
  Director
• Victor Clavelli,
  Chief Commercial Officer
• Anthony Krick,
  VP & Chief Accounting Officer
• Michele Janis MBA,
  VP & Acting CFO
• Dr. Per Gisle Djupesland M.D., Ph.D.,
  Co-Founder & Chief Scientific Officer of OptiNose AS
• Helena Kyttari Djupesland,
  Co-Founder of Optinose AS (Norway) & Co-CEO of Optinose AS (Norway)
• John Messina,
  Sr. VP of Clinical Devel. & Medical Affairs
• Karen E. Brophy,
  VP of HR
• Paul Mastrapa,
  CFO
• John N Kapoor,
  Director
• Edward A Blechschmidt,
  Director
• Leo Henikoff,
  Director
• Kenneth Abramowitz,
  Director
• Jerome Sheldon,
  Director
• Rajat Rai,
  CEO
• Joseph Bonaccorsi,
  Secretary
• Richard M Smith,
  President & COO
• Capital Partners Ii Gp, Llc...,
  
• Ventures Llctkwd Ventures L...,
  
• Fund Lp Entrepreneurs Fund ...,
  
• Rick Bierly,
  Director
• Sriram Venkataraman,
  Director
• Larry G Pickering,
  Director
• Thomas Edward Gibbs,
  Chief Commercial Officer
• Joshua Alexander Tamaroff,
  Director
• Robert P O'neil,
  Director
• Ventures Llc Wfd,
  10% owner
• Ventures Llc Tkwd,
  10% owner
• Anthony J Krick,
  Chief Accounting Officer
• Tomas J. Heyman,
  Director
• Kyle Dempsey,
  Director
• Eric Bednarski,
  Director
• R John Fletcher,
  Director
• Paul Jr. Spence,
  Chief Commercial Officer
• Michele Janis,
  Acting Chief Financial Officer